Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 18,553 |
|
|||||
| News | - | ||||||
| Day High | 4.07 | Low High |
|||||
| Day Low | 3.99 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Prelude Therapeutics Inc | PRLD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.03 | 0.74% | 4.07 | 16:30:09 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.04 | 3.99 | 4.07 | 4.07 | 4.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 308 | 18,553 | $ 4.01 | $ 74,421 | - | 1.66 - 6.89 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:34:00 | 10 | $ 3.96 | USD |
Prelude Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 220.78M | 54.92M | - | 0 | -121.83M | -2.22 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Prelude Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRLD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.45 | 4.13 | 3.44 | 3.90 | 54,085 | 0.62 | 17.97% |
| 1 Month | 4.76 | 5.83 | 3.42 | 4.47 | 47,174 | -0.69 | -14.50% |
| 3 Months | 3.25 | 5.83 | 2.62 | 4.08 | 70,743 | 0.82 | 25.23% |
| 6 Months | 2.09 | 5.83 | 1.66 | 3.26 | 141,103 | 1.98 | 94.74% |
| 1 Year | 5.87 | 6.89 | 1.66 | 3.72 | 125,549 | -1.80 | -30.66% |
| 3 Years | 36.36 | 45.33 | 1.66 | 13.67 | 189,832 | -32.29 | -88.81% |
| 5 Years | 25.76 | 95.375 | 1.66 | 20.82 | 192,940 | -21.69 | -84.20% |
Prelude Therapeutics Description
| Prelude Therapeutics Incorp is a clinical-stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet need. |
